Download A 13-Year-Old Boy with Persistent Emesis

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Growth hormone therapy wikipedia , lookup

Hyperandrogenism wikipedia , lookup

Hypothyroidism wikipedia , lookup

Hyperthyroidism wikipedia , lookup

Transcript
Case Challenge
A 13-Year-Old Boy with
Persistent Emesis
Alexandra H. Freeman, MD; Archana Pasupuleti, MD; and Allison Markowsky, MD, FAAP
A
previously healthy 13-year-old
boy presented to the emergency
department with a 1-month history of multiple episodes of emesis daily
accompanied by a 20-pound weight loss
during that period. The patient reports
that he was in his usual state of health
until approximately 1 month prior, when
he began to feel light-headed and dizzy.
A few days later, he began to have nonbloody, non-bilious, post-prandial emesis following intake of both solids and
liquids. Prior to each bout of emesis,
the patient reports a frontal, pounding
headache that is accompanied by palpitations, jitteriness, and white spots in
his visual fields. These associated symptoms are usually relieved with emesis.
The patient was seen by his primary care
physician several weeks prior and diagnosed with gastroenteritis. He was given
Alexandra Freeman, MD, is an Obstetrics & Gynecology Resident, Kaiser Permanente San Francisco. Archana Pasupuleti, MD, is a Child Neurology Fellow, Children’s National Medical Center.
Allison Markowsky, MD, FAAP, is Pediatric Hospitalist Attending, Assistant Professor of Pediatrics,
Children’s National Medical Center.
Address correspondence to: Allison Mar-
a trial of ranitidine, but that did not relieve his symptoms. He reported that the
symptoms progressively worsened over
the course of the month to three to four
times daily, prompting his mother to
bring him to the emergency room. Review of systems was negative for fevers,
chills, night sweats, shortness of breath,
chest or abdominal pain, change in urination or stool, weakness, tingling, or
numbness.
The patient has no significant medical
or surgical history, is up to date with his
vaccinations, takes no medication, and
has no known allergies. He lives with his
mother and attends middle school. He
denies illicit drug use, sexual activity, or
intentionally induced vomiting. Family
history is notable for gastroesophageal
reflux disease in his mother but is otherwise negative for infection, malignancy,
immunodeficiency, or endocrine or cardiac abnormalities.
In our emergency department, the
patient showed clinical signs of dehydration. His initial vital signs showed
tachycardia and positional hypotension.
On exam, he was a well-developed boy
who appeared comfortable and in no
acute distress. His neck was supple and
non-tender, and no lymphadenopathy or
masses were appreciated. His eyes appeared normal, with extra-ocular movements intact and pupils that were equal,
round, and reactive to light. Mucous
membranes were slightly dry. Cardiovascular examination was significant
for a grade II/VI systolic ejection murmur that was loudest at the left sternal
border and radiating to the apex. His
peripheral pulses were bounding but
equal bilaterally. His abdomen was soft,
non-tender, non-distended, with normal
active bowel sounds and no appreciable
organomegaly. Complete neurological
examination was normal.
In the emergency department, the patient was given two normal saline fluid
boluses. Urine and blood work were
sent, a purified protein derivative was
placed, and a chest radiograph (CXR)
and a head computed tomography (CT)
were performed. The patient was admitted to the general pediatric service for
dehydration and further workup of his
presenting symptoms.
Laboratory results were significant
for a slightly low white blood cell count
of 3.48k/mcL (normal, 3.84-9.8), elevated total bilirubin of 1.4 mg/dL (normal
kowsky, MD, FAAP, Children’s National Medical
Center, 111 Michigan Avenue NW, Suite M4800,
Washington, DC 20010; email: amarkows@
childrensnational.org.
Disclosure: The authors have no relevant financial relationships to disclose.
doi: 10.3928/00904481-20140221-06
104 | Healio.com/Pediatrics
For diagnosis, see page 105
Editor’s note: Each month, this department features a discussion of an unusual diagnosis in genetics, radiology, or dermatology. A description and images are presented,
followed by the diagnosis and an explanation of how the diagnosis was determined. As
always, your comments are welcome via email at [email protected].
PEDIATRIC ANNALS 43: 3 | MARCH 2014
Case Challenge
< 0.8), and elevated uric acid of 9.5 mg/
dL (normal 2.7-6.8); lactic dehydrogenase was normal. The remainder of his
complete blood count and basic chemistry panel were all within normal limits. Urinalysis revealed elevated total
protein and ketones but was otherwise
normal. CXR and head CT were found
to be normal.
Diagnosis:
Hyperthyroidism Caused by
Graves’ Disease
The patient’s thyroid-stimulating
hormone (TSH) level came back significantly suppressed, at < 0.01 milliinternational units/L (normal, 0.525.08), most likely indicating a hyperthyroid state. At this time, our endocrinology team was consulted and a complete
thyroid function panel, thyroid peroxidase (TPO) antibodies, and thyroidstimulating immunoglobulin (TSI) were
obtained. The results were indicative
of hyperthyroidism caused by Graves’
disease. Initial thyroid laboratory results included T3 of 402 ng/dL (normal,
60-228), free T4 of 8.09 ng/dL (normal,
1-1.6), TSI of 365 microinternational
units/mL (normal < 140), and thyroid
peroxidase antibody (TPO) antibody of
259 international units/mL (normal <
35). Given that there is mention in the
literature of associated or concomitant
adrenal insufficiency with Graves’ thyrotoxicosis, an adrenocorticotropic hormone level and random serum cortisol
level were also drawn but were found to
be normal.1
DISCUSSION
Our patient presented with atypical
symptoms of an already rare disease in
children. Only approximately 5% of patients with hyperthyroidism are younger
than age 15 years. In children, Graves’
PEDIATRIC ANNALS 43:3 | MARCH 2014
disease is the leading cause of hyperthyroidism. It occurs more frequently
in girls than in boys and often presents
in adolescence.2 The classic manifestations of hyperthyroidism are the wellrecognized conglomerate of symptoms
that can include weight loss, heat intolerance, palpitations, excessive sweating, nervousness, muscle weakness,
fatigue, sleep disturbance, increased
hunger, oligomenorrhea, and diarrhea.
Clinical signs of hyperthyroidism may
also include tremor, tachycardia, bruit,
brisk deep tendon reflexes, lid lag, moist
palms, or goiter. Signs more specific for
Graves’ disease include a diffuse goiter, opthalmopathy, and dermatopathy.
Although a combination of the above
symptoms can make the diagnosis
easier, the initial development of symptoms, especially in children, can often
be subtle and non-specific, making the
diagnosis more challenging.
Although our patient exhibited a
few of the typical symptoms (including
weight loss, palpitations, and tachycardia), these symptoms and findings
were secondary and non-specific. His
primary complaint and only reason for
seeking medical attention was the persistent emesis.
Hyperemesis and Hyperthyroidism
Severe, persistent vomiting is an
uncommon presentation of hyperthyroidism; however, there have been a
few isolated case studies in adults that
have reported emesis as the presenting
symptom of thyrotoxicosis. Hoogendoorn and Cools3 described a case of
a 32-year-old woman found to have
Graves’ disease who presented with
persistent vomiting, epigastric pain,
and weight loss. The patient was treated
with propylthiouracil and a beta-blocker, with resolution of symptoms within
1 day. Similarly, Chen et al4 reported
severe post-prandial vomiting (two to
three times daily) and weight loss as
the prominent sign of hyperthyroidism
in a 24-year-old Chinese man. The only
mention of vomiting as the main symptom of hyperthyroidism that we could
find in the pediatric population was in
a German medical journal where a 12year old boy presented with sudden onset of recurrent nausea and vomiting.5
Thyrotoxicosis itself is defined as
the clinical syndrome occurring when
tissues are exposed to excess amounts
of thyroid hormone. The mechanism of
emesis caused by thyrotoxicosis is unknown. It has been suggested that excess thyroid hormone may directly alter
gastric motility, affecting propulsion of
the gastrointestinal tract. Alternatively,
excess thyroid hormone may also stimulate the chemoreceptor trigger zone in
the central nervous system, thereby contributing to emesis.6
The sympathomimetic effect of increased beta-adrenergic activity and elevated levels of beta-adrenergic receptors
in thyrotoxicosis is well understood to
account for more classic presentations
of hyperthyroidism, including tachycardia, tremulousness, anxiety, and
palpitations. This mechanism is readily
supported by the fact that beta-blockers
rapidly resolve these symptoms. Similarly, increased beta-adrenergic receptor
activity may also account for hyperemesis in the hyperthyroid state. Several
studies have suggested this mechanism,
with the observation of complete resolution of hyperemesis following administration of a beta-blocking agent.3,7
Similarly, the clinical syndrome of
hyperemesis gravidum, a severe and
persistent nausea and vomiting that often leads to weight loss and dehydration in early pregnancy, may prove to
be an important correlation between
hormones and emesis. The prevalence
of hyperemesis gravidum is estimated to be 0.3% to 2%, increasing with
Healio.com/Pediatrics | 105
Case Challenge
multiple pregnancies and in gestational trophoblastic disease secondary
to elevated levels of human chorionic
gonadotrophin (HCG) levels.8 This
glycoprotein hormone is secreted by
the placenta and the unique beta subunit confers specificity of HCG, which
comprises the pregnancy screening test.
The alpha subunit, however, is shared
with TSH and follicular-stimulating
hormone. As such, HCG has thyroidstimulating properties, and pregnant
women with hyperemesis gravidum
are commonly found to have relatively
higher levels of T4 and T3 and lower
levels of TSH when compared with
other pregnant women.9-11 It has been
suggested that these elevated levels of
fasting thyroid hormones may be a contributing factor to hyperemesis in this
setting of early pregnancy.
FOLLOW-UP
Once diagnosed, our patient began
treatment for his hyperthyroidism with
methimazole, which inhibits thyroid
hormone synthesis by blocking the oxidation of iodine in the thyroid gland.
106 | Healio.com/Pediatrics
His symptoms improved quickly and
he was discharged shortly afterwards.
Since discharge, he has been followed
closely by our Endocrinology service,
and although compliance has been an
ongoing issue, his symptoms have been
well controlled when he takes the medication as prescribed.
CONCLUSIONS
Although there have been a few case
reports in adults that have described
hyperemesis as the chief complaint in
newly diagnosed hyperthyroidism and
thyrotoxic states, our case represents a
unique description of this atypical and
rare presentation of hyperthyroidism in
the pediatric population in the United
States. It reminds us that we need to be
thorough when obtaining a review of
systems as well as keeping a broad differential when investigating prolonged,
unexplained emesis.
REFERENCES
1.Karl M, Onumah BM, Cole J, et al. Hypocortisolemia in Graves hyperthyroidism. Endocr
Pract. 2009;15(3):220-224.
2.Kliegman R, Nelson WE. Nelson Textbook of
Pediatrics. 19th ed. Philadelphia, PA: Elsevier
Saunders; 2011:1909-1913.
3.Hoogendoorn EH, Cools BM. Hyperthyroidism
as a cause of persistent vomiting. Neth J Med.
2004;62(8):293-296.
4. Chen LY, Zhou B, Chen ZW, Fang LZ. Case report: recurrent severe vomiting due to hyperthyroidism. J Zhejiang Univ Sci B. 2010;11(3):218220.
5.Muller-Michaels J, Burk G, Andler W. [Vomiting as main symptom: unusual presentation of a
hyperthyroidism in a 12-year-old boy]. [Article
in German]. Klin Padiatr. 1997;209(3):141-143.
6. Braverman LE, Ingbar SH, Werner SC. Werner’s
the Thyroid: A Fundamental and Clinical Text.
5th ed. Philadelphia, PA: Lippincott; 1986:871878.
7. Dreyfuss AI. Protracted epigastric pain and vomiting as a presentation of thyrotoxicosis. J Clin
Gastroenterol. 1984;6(5):435-436.
8.Eliakim R, Abulafia O, Sherer DM. Hyperemesis gravidarum: a current review. Am J Perinatol.
2000;17(4):207-218.
9. Lazarus JH, Kokandi A. Thyroid disease in relation to pregnancy: a decade of change. Clin Endocrinol (Oxf). 2000;53(3):265-278.
10.Goodwin TM, Montoro M, Mestman JH, Pekary AE, Hershman JM. The role of chorionic
gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab.
1992;75(5):1333-1337.
11. Kimura M, Amino N, Tamaki H, et al. Gestational thyrotoxicosis and hyperemesis gravidarum:
possible role of hCG with higher stimulating
activity. Clin Endocrinol (Oxf). 1993;38(4):345350.
PEDIATRIC ANNALS 43: 3 | MARCH 2014